The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing

By EP News Bureau on November 7, 2014

Related Posts

Indore Rising: Central India’s next manufacturing powerhouse

Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics

Panel Discussion: From molecule to market faster: Rethinking drug development

Prof (Dr) Neelesh Malviya, Principal, Smriti College of Pharmaceutical Education, Indore

Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab

Mr Ranjit Menon, Site Head – Indore – Manufacturing, Cipla

Mr Akil Kadiyavala, GM – Technical Services, Dhara Lifescience
Comments (0)
Add Comment